Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances
September 7, 2021
Tags:
Pharma’s Almanac Scientific Editor in Chief David Alvaro met with Andelyn’s Mayo Pujols and Wade Macedone to discuss the challenges facing gene therapy developers and how Andelyn’s history and unique perspective help drive innovation in the sector.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
